Detailed Information
Cited 25 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
CNS response to osimertinib vs standard of care (SoC) EGFR-TKI as first-line therapy in patients (pts) with EGFR-TKI sensitising mutation (EGFRm)-positive advanced non-small cell lung cancer (NSCLC): Data from the FLAURA study
- Authors
- Vansteenkiste, J.; Reungwetwattana, T.; Nakagawa, K.; Cho, B. C.; Cobo Dols, M. A.; Cho, E. K.; Bertolini, A.; Bohnet, S.; Zhou, C.; Lee, K. H.; Nogami, N.; Okamoto, I.; Leighl, N.; Hodge, R.; McKeown, A.; Brown, A. P.; Rukazenkov, Y.; Ramalingam, S.
- Issue Date
- Nov-2017
- Publisher
- OXFORD UNIV PRESS
- Citation
- ANNALS OF ONCOLOGY, v.28, pp.189 - 189
- Journal Title
- ANNALS OF ONCOLOGY
- Volume
- 28
- Start Page
- 189
- End Page
- 189
- ISSN
- 0923-7534
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Cho, Eun Kyung
- College of Medicine (Department of Medicine)